The role of carbapenems in initial therapy for serious Gram-negative infections.
about
Antibiotic susceptibility pattern of Enterobacteriaceae and non-fermenter Gram-negative clinical isolates of microbial resource orchid.In vitro pharmacodynamics of various antibiotics in combination against extensively drug-resistant Klebsiella pneumoniae.Optimizing the use of carbapenems in the face of increasing Gram-negative resistanceIntegrated pharmacokinetic-pharmacodynamic modeling to evaluate empiric carbapenem therapy in bloodstream infections
P2860
The role of carbapenems in initial therapy for serious Gram-negative infections.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 May 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The role of carbapenems in initial therapy for serious Gram-negative infections.
@en
The role of carbapenems in initial therapy for serious Gram-negative infections.
@nl
type
label
The role of carbapenems in initial therapy for serious Gram-negative infections.
@en
The role of carbapenems in initial therapy for serious Gram-negative infections.
@nl
prefLabel
The role of carbapenems in initial therapy for serious Gram-negative infections.
@en
The role of carbapenems in initial therapy for serious Gram-negative infections.
@nl
P2860
P921
P356
P1433
P1476
The role of carbapenems in initial therapy for serious Gram-negative infections.
@en
P2093
James J Rahal
P2860
P2888
P356
10.1186/CC6821
P478
12 Suppl 4
P577
2008-05-21T00:00:00Z
P5875
P6179
1032183958